LATEST
Agreement signedPublished 12 Dec 2022

DIV Acquisition V, LLC /
Rubius Therapeutics, Inc.

DIV Acquisition V to buy Rubius Therapeutics property

Terms
Not stated
Stage
Agreement signed
Buy side: DIV Acquisition V, LLC
Buy sideDIV Acquisition V, LLC
Target: Rubius Therapeutics, Inc.
TargetRubius Therapeutics, Inc.
Source · 12 Dec 2022
Buy side: DIV Acquisition V, LLC
Buy sideDIV Acquisition V, LLC
Target: Rubius Therapeutics, Inc.
TargetRubius Therapeutics, Inc.
01 / BuyerDIV Acquisition V, LLC
02 / TargetRubius Therapeutics, Inc.
01

What happened

Rubius Therapeutics, Inc. agreed to sell two Rhode Island properties, including its manufacturing facility, to DIV Acquisition V, LLC for $18,500,000, subject to adjustment. The transaction is subject to customary closing conditions and is expected to close on Dec. 21, 2022.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

DIV Acquisition V to buy Rubius Therapeutics property

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

  2. Expected close

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.